Terence Joseph Cusack Iv is a pharmacist who is specialized in Pharmacotherapy in Twentynine Palms, California. Patients can reach him at 1145 Sturgis Street, Twentynine Palms or contact him on 760-830-2202. Active license number of Terence Joseph Cusack Iv is 67215 for Pharmacotherapy in California. Terence Joseph Cusack Iv is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Terence Joseph Cusack Iv speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Terence Joseph Cusack Iv are as mentioned below.
NPI Number:
1740531235
NPI Enumeration Date:
25 Sep, 2012
NPI Last Update On:
02 Mar, 2022
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Terence Joseph Cusack Iv are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
67215
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
401 Holland Ln, 513 Alexandria, Virginia
Zip:
22314-3428
Phone Number:
760-464-8022
Fax Number:
--
Patients can reach Terence Joseph Cusack Iv at 1145 Sturgis Street, Twentynine Palms, California or can call on phone at 760-830-2202.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.